Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440115 · ClinicalTrials.gov registry record · Phase 3
Disease Management for Smoking Cessation
A Phase 3 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 750
- Enrollment target
- 1
- Study location
NCT00440115 is a Phase 3 study of Smoking Cessation that has completed, run by University of Kansas Medical Center. The registered enrollment target is 750 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00440115, a Phase 3 study of Smoking Cessation, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the number of quit attempts, and smokers motivation at 24 months between participants receiving high and low intensity disease management and those receiving usual care.
Conditions Studied
Interventions
- DRUG Bupropion
- BEHAVIORAL High intensity disease management
- BEHAVIORAL Low intensity disease management
- BEHAVIORAL Comparison group
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00440115
The ClinicalTrials.gov registry entry for NCT00440115 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (59% higher). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Bupropion is the first listed.
NCT00440115 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT00440115 about?
NCT00440115 is a clinical study titled "Disease Management for Smoking Cessation". The primary aim of this study is to assess the effectiveness of both high and low intensity, disease management programs for smoking. The hypotheses are to compare abstinence from cigarettes, the number of quit attempts, and smokers motivation at 24 months between participants receiving high and low...
What is the current status of trial NCT00440115?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 750 participants. The study started on 2009-06. Estimated completion is 2010-12.
What conditions does trial NCT00440115 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00440115?
The interventions under investigation include: Bupropion (DRUG), High intensity disease management (BEHAVIORAL), Low intensity disease management (BEHAVIORAL), Comparison group (BEHAVIORAL).
Who is sponsoring clinical trial NCT00440115?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00440115 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tobacco Education and Lung Health Study (TEAL)
RECRUITING · Phase 3
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
-
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
RECRUITING · Phase 3
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
COMPLETED · Phase 3
-
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
COMPLETED · Phase 3
-
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.